Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study
- PMID: 11545679
- PMCID: PMC55336
- DOI: 10.1186/1471-5945-1-5
Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study
Abstract
Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is a skin cancer therapy that still has limitations due to the low penetration of this drug into the skin. We have proposed in this work a delivery system for 5-ALA based on liposomes having lipid composition similar to the mammalian stratum corneum (SCLLs) in order to optimize its skin delivery in Photodynamic Therapy (PDT) of skin cancers.
Methods: SCLLs were obtained by reverse phase evaporation technique and size distribution of the vesicles was determinated by photon correlation spectroscopy. In vitro permeation profile was characterized using hairless mouse skin mounted in modified Franz diffusion cell.
Results: Size exclusion chromatography on gel filtration confirmed vesicle formation. SCLLs obtained by presented a degree of encapsulation of 5-ALA around 5.7%. A distribution of vesicle size centering at around 500 nm and 400 nm respectively for SCLLs and SCLLs containing 5-ALA was found. In vitro 5-ALA permeation study showed that SCLLs preparations presented higher skin retention significantly (p < 0.05) on the epidermis without SC + dermis, with a decreasing of skin permeation compared to aqueous solution.
Conclusions: The in vitro delivery performance provided by SCLLs lead to consider this systems adequate for the 5-ALA-PDT of skin cancer, since SCLLs have delivered 5-ALA to the target skin layers (viable epidermis + dermis) to be treated by topical PDT of skin cancer.
Figures



Similar articles
-
Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.Eur J Pharm Sci. 2011 Sep 18;44(1-2):149-57. doi: 10.1016/j.ejps.2011.07.003. Epub 2011 Jul 12. Eur J Pharm Sci. 2011. PMID: 21782942
-
Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.Int J Pharm. 2008 May 22;356(1-2):144-52. doi: 10.1016/j.ijpharm.2008.01.020. Epub 2008 Jan 19. Int J Pharm. 2008. PMID: 18325699
-
In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy.J Control Release. 2003 Apr 29;89(2):261-9. doi: 10.1016/s0168-3659(03)00125-1. J Control Release. 2003. PMID: 12711449
-
Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.J Drugs Dermatol. 2004 Jan-Feb;3(1 Suppl):S26-31. J Drugs Dermatol. 2004. PMID: 14964758 Review.
-
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.Cancer. 1997 Jun 15;79(12):2282-308. doi: 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o. Cancer. 1997. PMID: 9191516 Review.
Cited by
-
A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.Int J Med Sci. 2016 Jun 18;13(7):483-9. doi: 10.7150/ijms.15411. eCollection 2016. Int J Med Sci. 2016. PMID: 27429584 Free PMC article.
-
Unveiling the potential of photodynamic therapy with nanocarriers as a compelling therapeutic approach for skin cancer treatment: current explorations and insights.RSC Adv. 2024 Jul 10;14(30):21915-21937. doi: 10.1039/d4ra02564d. eCollection 2024 Jul 5. RSC Adv. 2024. PMID: 38989245 Free PMC article. Review.
-
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments.Neoplasia. 2022 Aug;30:100810. doi: 10.1016/j.neo.2022.100810. Epub 2022 May 29. Neoplasia. 2022. PMID: 35649306 Free PMC article. Review.
-
Micro- and Nano-Based Transdermal Delivery Systems of Photosensitizing Drugs for the Treatment of Cutaneous Malignancies.Pharmaceuticals (Basel). 2021 Aug 6;14(8):772. doi: 10.3390/ph14080772. Pharmaceuticals (Basel). 2021. PMID: 34451868 Free PMC article. Review.
-
Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities.Pharmaceutics. 2021 Jun 26;13(7):960. doi: 10.3390/pharmaceutics13070960. Pharmaceutics. 2021. PMID: 34206728 Free PMC article. Review.
References
-
- Robinson DJ, Bruijn HS, Van Der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998;67:140–149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical